Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Mylimus 0.1% Ointment 10gm
Mylimus 0.1% Ointment 10gm
Manufacturer/Marketed By : MYLAN PHARMACEUTICALS PVT LTD
$3.44 $2.75
Mylimus 0.1% ointment 10gm contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. It is used to treat moderate to...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TACROLIMUS
Active Pharmaceutical Ingredient
Mylimus 0.1% Ointment 10gm
3,44 US$
2,75 US$
Mylimus 0.1% ointment 10gm contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. It is used to treat moderate to severe atopic dermatitis (eczema) in adults who cannot use other medications for their condition or whose eczema has not responded to other medications. It suppresses the immune system from producing substances that may develop eczema. Do not take this mylimus 0.1% ointment 10gm if you are allergic to tacrolimus or any of the other ingredients of this medicine. Report your physician if you are allergic to any antibiotic group. Inform your doctor if you have or had a liver failure, skin problems or skin cancer, or a weakened immune system. Notify your physician immediately if you develop fever, bruising under the skin (which may appear as red dots), unexplained tiredness, confusion, yellowing of the skin or eyes, reduced urine output, vision loss, and seizures after taking this medicine. Limit exposure to sunlight and UV light while consuming mylimus 0.1% ointment 10gm by wearing appropriate protective clothing and sunscreen with a high sun protection factor. This is because of the potential risk of malignant skin changes with immunosuppressive therapy. Do not apply this ointment to the infected areas if you have infected lesions. If you notice any change in the appearance of your skin, consult your physician immediately. This medicine is not approved for children younger than 16 years of age.
Active Pharmaceutical Ingredient
Usos
• Moderate to severe atopic dermatitis (eczema)
Beneficios
Mylimus 0.1% ointment 10gm provides immunosuppression by inhibiting T-lymphocyte activation and proliferation and T-helper-cell-dependent B-cell response. It works by attaching to a protein called FKBP-12 and forms a complex called tacrolimus-FKBP, which inhibits the action of calcineurin phosphatase. This, in turn, inhibits the formation of T cells and suppresses the immune response.
Efectos secundarios
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Efectos secundarios más comunes
• Burning sensation and itching
• Redness, feeling or warmth
• Pain
• Increased skin sensitivity to hot and cold
• Skin tingling
• Rash
Efectos secundarios comunes
• Acne
• Facial redness
• Eye infections
• Lentigo (flat brown spots on the skin)
• Cold sores
• Swelling of the hands, arms, feet, ankles, or lower legs
Cómo utilizar
This medicine is only for topical use. Always use mylimus 0.1% ointment 10gm exactly as advised by your doctor. Apply the ointment as a thin layer to the affected areas of your skin. Avoid using the ointment inside your nose, mouth, or eyes. Before using the ointment, be sure your skin is completely dry. Your doctor will say the exact amount and time you should use this ointment. If you accidentally swallowed the ointment, contact your physician immediately and seek medical advice.
Consejos de seguridad
• Breast Feeding: Do not consume mylimus 0.1% ointment 10gm if you are breastfeeding because this medicine is excreted into breast milk and may cause harmful effects on the body.
• Alcohol: It is unsafe to consume alcohol when taking mylimus 0.1% ointment 10gm because it may cause the skin or face to become flushed or red and feel hot.
• Liver: Mylimus 0.1% ointment 10gm should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether mylimus 0.1% ointment 10gm can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: It is unknown whether mylimus 0.1% ointment 10gm can impair the ability to drive. Consult your doctor for more advise.
• Pregnancy: Based on animal studies, mylimus 0.1% ointment 10gm can cause harmful effects on the baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant before initiating the treatment.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.



